Cargando…
A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts”
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389302/ https://www.ncbi.nlm.nih.gov/pubmed/36799779 http://dx.doi.org/10.1097/JS9.0000000000000078 |
_version_ | 1785082268405989376 |
---|---|
author | Liu, Zhi-Peng Dai, Hai-Su Zhang, Yan-Qi Yin, Xian-Yu Chen, Zhi-Yu |
author_facet | Liu, Zhi-Peng Dai, Hai-Su Zhang, Yan-Qi Yin, Xian-Yu Chen, Zhi-Yu |
author_sort | Liu, Zhi-Peng |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10389302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-103893022023-08-01 A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts” Liu, Zhi-Peng Dai, Hai-Su Zhang, Yan-Qi Yin, Xian-Yu Chen, Zhi-Yu Int J Surg Editorials Lippincott Williams & Wilkins 2023-01-12 /pmc/articles/PMC10389302/ /pubmed/36799779 http://dx.doi.org/10.1097/JS9.0000000000000078 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Editorials Liu, Zhi-Peng Dai, Hai-Su Zhang, Yan-Qi Yin, Xian-Yu Chen, Zhi-Yu A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts” |
title | A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts” |
title_full | A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts” |
title_fullStr | A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts” |
title_full_unstemmed | A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts” |
title_short | A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts” |
title_sort | commentary on “an artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts” |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389302/ https://www.ncbi.nlm.nih.gov/pubmed/36799779 http://dx.doi.org/10.1097/JS9.0000000000000078 |
work_keys_str_mv | AT liuzhipeng acommentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts AT daihaisu acommentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts AT zhangyanqi acommentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts AT yinxianyu acommentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts AT chenzhiyu acommentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts AT liuzhipeng commentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts AT daihaisu commentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts AT zhangyanqi commentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts AT yinxianyu commentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts AT chenzhiyu commentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts |